What happened
Biotrend and German company Uniper Global Commodities SE (UGC) signed a non-binding letter of intent in Istanbul on 30 September 2026. The agreement was concluded during a business forum connected with Türkiye and the German state of North Rhine-Westphalia.
The document sets out discussions on a possible commercial relationship for biomethane that Biotrend plans to produce at facilities in Türkiye. UGC may purchase the fuel, but the letter does not establish a supply contract or require either party to trade.
Under the envisaged approach, UGC could serve as a prospective offtaker for biomethane once Biotrend has secured feedstock and met the relevant sustainability, inspection, certification and registration requirements. The parties will first examine production options and routes to European markets.
For companies following the transaction, the immediate point is that it is an early-stage market assessment rather than confirmed biomethane demand or contracted capacity. Progress should be judged against later negotiations and any binding agreements.
Why it matters
The letter creates a framework for considering whether biomethane made in Türkiye could reach European markets. It also puts sustainability compliance and product verification at the centre of any potential supply arrangement, alongside feedstock availability.
However, material commercial details remain open. The companies have not agreed possible sales volumes, price methodology or other trading conditions. Those matters are intended for future negotiations and would need to be recorded in definitive binding contracts.
The arrangement also carries no obligation for Biotrend or UGC to invest, sell or buy. It should therefore not be read as confirmation of a project investment, a guaranteed buyer, or a committed biomethane flow.
What comes next
The first phase concerns assessment of biomethane production and opportunities for access to European customers. Any later projects will be considered in light of the applicable regulatory setting, certification processes, and technical and commercial feasibility.
Biotrend would need to address feedstock supply and the specified sustainability, inspection, certification and registration steps for products considered under the framework. UGC's potential role remains subject to the outcome of those assessments and subsequent commercial discussions.
Market participants should watch for disclosure of negotiated volumes, pricing arrangements or final contracts. Until then, the letter remains a non-binding basis for evaluating cooperation rather than an executed supply deal.
